ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Trials Approved In October

December 28, 2001

DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off

June 1, 2001

DCPC Advisors Commit $32 Mil. To Chemoprevention

June 7, 1991

Treatment research Reports Summarized; New MTX Rescues

May 6, 1977

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

Brown Needs Decision By March 31; Sander Decline HEW Offer

March 4, 1977